XML 24 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Mar. 01, 2025
Mar. 02, 2024
Cash Flows from Operating Activities:    
Net earnings $ 23.0 $ 73.6
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 104.6 111.6
Stock-based compensation 24.0 17.1
Amortization of deferred financing costs 3.5 3.5
Bad debt expense 4.4 3.1
Loss on sale of equity method investment 0.0 0.4
Operating leases 3.0 (7.0)
Deferred taxes (8.3) (0.3)
Gain (loss) on sale of property 0.8 (0.4)
Restructuring expense 4.2 8.7
Impairment expense 130.0 0.0
(Increase) decrease in current assets (146.0) 100.0
(Decrease) in current liabilities (4.9) (32.9)
(Decrease) in non-current liabilities (0.6) (2.1)
Other, net 0.7 (1.4)
Net Cash Provided by Operating Activities 138.4 273.9
Cash Flows from Investing Activities:    
Proceeds from sale of property 6.2 0.6
Advances of notes receivable (3.1) (10.6)
Collection of notes receivable 5.7 2.1
Proceeds from the sale of equity method investment 0.0 3.5
Capital expenditures (68.1) (56.5)
Other, net (1.0) (0.1)
Net Cash Used in Investing Activities (60.3) (61.0)
Cash Flows from Financing Activities:    
Repayments of long-term debt (29.7) (22.2)
Proceeds from credit facility 702.5 620.1
Repayments of credit facility (678.5) (668.9)
Dividends paid (39.0) (42.2)
Common stock issued 5.2 4.3
Common stock repurchased and retired (84.8) (101.0)
Distribution to noncontrolling interest (4.4) (2.8)
Other, net 1.1 (0.4)
Net Cash Used in Financing Activities (127.6) (213.1)
Effect of Exchange Rate Changes on Cash and Cash Equivalents (11.1) 0.3
Net (Decrease) Increase in Cash and Cash Equivalents (60.6) 0.1
Cash and Cash Equivalents, Beginning of Period 230.4 223.5
Cash and Cash Equivalents, End of Period $ 169.8 $ 223.6